The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 984.20
Bid: 983.80
Ask: 984.40
Change: -13.40 (-1.34%)
Spread: 0.60 (0.061%)
Open: 997.60
High: 998.40
Low: 982.20
Prev. Close: 997.60
PSON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

3 Oct 2022 15:40

RNS Number : 6081B
Pearson PLC
03 October 2022
 

 

Pearson plc - (the "Company")

 

Notification of PDMRs' Interests

 

 

The following notifications, made in accordance with the requirements of the UK Market Abuse Regulation, give details of purchases of ordinary shares of 25p each, made under the Company's Dividend Reinvestment Plan ("DRIP").

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Andy Bird

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pearson plc

b)

LEI

2138004JBXWWJKIURC57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

American Depositary Receipts (ADRs) in Pearson plc, each ADR represents one ordinary share of 25 pence in Pearson plc

 

ISIN: US7050151056

b)

Nature of the transaction

Purchase of ADRs arising from Company's Dividend Reinvestment Plan ("DRIP")

c)

Price(s) and volume(s)

Price(s)

Volume(s)

$9.19 per ADR

1,732

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: 1,732

Aggregated price: $15,917.08

e)

Date of the transaction

29 September 2022

f)

Place of the transaction

New York Stock Exchange (NYSE)

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Arthur Valentine

2

Reason for the notification

a)

Position/status

President - Assessment and Qualifications

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pearson plc

b)

LEI

2138004JBXWWJKIURC57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

American Depositary Receipts (ADRs) in Pearson plc, each ADR represents one ordinary share of 25 pence in Pearson plc

 

ISIN: US7050151056

b)

Nature of the transaction

Purchase of ADRs arising from Company's Dividend Reinvestment Plan ("DRIP")

c)

Price(s) and volume(s)

Price(s)

Price(s) and volume(s)

$9.19 per ADR

61

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: 61

Aggregated price: $560.59

e)

Date of the transaction

29 September 2022

f)

Place of the transaction

New York Stock Exchange (NYSE)

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Thomas ap Simon

2

Reason for the notification

a)

Position/status

President - Higher Education and Virtual Learning

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Pearson plc

b)

LEI

2138004JBXWWJKIURC57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

American Depositary Receipts (ADRs) in Pearson plc, each ADR represents one ordinary share of 25 pence in Pearson plc

 

ISIN: US7050151056

b)

Nature of the transaction

Purchase of ADRs arising from Company's Dividend Reinvestment Plan ("DRIP")

c)

Price(s) and volume(s)

Price(s)

Price(s) and volume(s)

$9.19 per ADR

130

d)

Aggregated information

- Aggregated volume

- Price

 

Aggregated volume: 130

Aggregated price: $1,194.70

e)

Date of the transaction

29 September 2022

f)

Place of the transaction

New York Stock Exchange (NYSE)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFZMGGDFRGZZM
Date   Source Headline
14th Jun 20235:17 pmRNSHolding(s) in Company
1st Jun 202312:32 pmRNSBlock listing Interim Review
1st Jun 202312:28 pmRNSTotal Voting Rights
26th May 20234:48 pmRNSHolding(s) in Company
19th May 20233:00 pmRNSDirector/PDMR Shareholding
17th May 20234:50 pmRNSDirector/PDMR Shareholding
16th May 20234:16 pmRNSDirector/PDMR Shareholding
10th May 20234:30 pmRNSDirector/PDMR Shareholding
10th May 202310:49 amRNSDirectorate Change
9th May 20234:15 pmRNSHolding(s) in Company
9th May 20239:00 amRNSPearson: Generative AI Strategy Update
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
3rd May 20234:13 pmRNSHolding(s) in Company
2nd May 20233:57 pmRNSTotal Voting Rights
28th Apr 20231:11 pmRNSResult of AGM
28th Apr 20237:00 amRNSPearson 2023 Q1 Trading Update
20th Apr 20234:19 pmRNSHolding(s) in Company
11th Apr 20239:17 amRNSHolding(s) in Company
4th Apr 20234:30 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 20233:00 pmRNSTotal Voting Rights
31st Mar 20233:44 pmRNSForm 20-F for the year ended 31 December 2022
31st Mar 20232:29 pmRNSHolding(s) in Company
28th Mar 202311:17 amRNSDirector Declaration
27th Mar 20234:05 pmRNSHolding(s) in Company
24th Mar 202312:30 pmRNSNotice of AGM
23rd Mar 20237:00 amRNSPearson Completes Acquisition of PDRI
21st Mar 20237:00 amRNSPearson to sell POLS
16th Mar 20233:09 pmRNSAnnual Financial Report
16th Mar 202311:28 amRNSDirector Declaration
7th Mar 20234:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSPearson 2022 Preliminary Results
2nd Mar 20233:37 pmRNSCommittee Change
1st Mar 202310:10 amRNSTotal Voting Rights
8th Feb 20232:37 pmRNSHolding(s) in Company
3rd Feb 20234:23 pmRNSDirector/PDMR Shareholding
1st Feb 202311:10 amRNSTotal Voting Rights
18th Jan 20237:00 amRNSPearson 2022 Trading Update
4th Jan 20233:04 pmRNSDirector/PDMR Shareholding
3rd Jan 20239:25 amRNSTotal Voting Rights
19th Dec 202212:02 pmRNSDirector/PDMR Shareholding
19th Dec 202212:00 pmRNSPearson to Acquire PDRI
16th Dec 20224:38 pmRNSCompletion of Redemption - Guaranteed Notes
14th Dec 20222:52 pmRNSSecond/Further Notice - Guaranteed Notes
7th Dec 20226:06 pmRNSTransaction in Own Shares
6th Dec 20226:02 pmRNSTransaction in Own Shares
5th Dec 20225:55 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.